Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Active Not Recruiting Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04362189Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19